Kingdon Capital

Kingdon Capital provide services to high net worth individuals and institutional clients. They employ a top-down approach to select the economies and fundamental and technical analysis with a bottom-up stock picking approach to invest. They invest in growth and value stocks, currency futures, options and long/short strategies.

They have exited investments in Stealth BioTherapeutics, SteadyMed Therapeutics, MFormation Technologies, Napo Pharmaceuticals, Bill Me Later, SafeWeb, SandCraft and Luminous Networks.

Kingdon Capital has made investments in Message Media, SandCraft, Luminous Networks, SafeWeb, Mformation Technologies, Bill Me Later, Napo Pharmaceuticals, SteadyMed TherapeuticsSteadyMed Therapeutics, and Stealth BioTherapeutics.

Kingdon Capital has made investments in Message Media, SandCraftSandCraft, Luminous Networks, SafeWeb, Mformation Technologies, Bill Me Later, Napo Pharmaceuticals, SteadyMed Therapeutics, and Stealth BioTherapeutics.

Kingdon Capital has made investments in Message Media, SandCraft, Luminous Networks, SafeWeb, Mformation TechnologiesMformation Technologies, Bill Me Later, Napo Pharmaceuticals, SteadyMed Therapeutics, and Stealth BioTherapeutics.

Founded in 1983 by Mark Kingdon, Kingdon Capital is a New York CityNew York City based alternative investment firm and registered investment adviser.

They have exited investments in Stealth BioTherapeuticsStealth BioTherapeutics, SteadyMed Therapeutics, MFormation Technologies, Napo Pharmaceuticals, Bill Me Later, SafeWeb, SandCraft and Luminous Networks.